Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant

por Aldredge, Lakshi M., Young, Melodie S.
Publicado 2016

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic disease

por Young, Melodie, Roebuck, Heather L.
Publicado 2016

A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up

por Cather, Jennifer, Young, Melodie, DiRuggiero, Douglas C., Tofte, Susan, Williams, Linda, Gonzalez, Tayler
Publicado 2022

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1

por Strober, Bruce E., Clay Cather, Jennifer, Cohen, David, Crowley, Jeffrey J., Gordon, Kenneth B., Gottlieb, Alice B., Kavanaugh, Arthur F., Korman, Neil J., Krueger, Gerald G., Leonardi, Craig L., Schwartzman, Sergio, Sobell, Jeffrey M., Solomon, Gary E., Young, Melodie
Publicado 2012

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2

por Strober, Bruce E., Clay Cather, Jennifer, Cohen, David, Crowley, Jeffrey J., Gordon, Kenneth B., Gottlieb, Alice B., Kavanaugh, Arthur F., Korman, Neil J., Krueger, Gerald G., Leonardi, Craig L., Schwartzman, Sergio, Sobell, Jeffrey M., Solomon, Gary E., Young, Melodie
Publicado 2012